BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HS, Choi SI, Lee HK, Kim HS, Yang HK, Kang GH, Kim YI, Lee BL, Kim WH. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 2002;15:632-40. [PMID: 12065777 DOI: 10.1038/modpathol.3880578] [Cited by in Crossref: 109] [Cited by in F6Publishing: 117] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Boyer C, Sefrioui D, Cohen R, Chautard R, Perrier M, Lebrun H, Goujon G, Hautefeuille V, Dior M, Walter T, Mary F, Manfredi S, Caroli-Bosc FX, Cervantes B, Coriat R, Deluche E, Zaanan A, Olivier R, Bouché O, Piessen G, Lecomte T, Louvet C, Michel P, Aparicio T, André T, Taieb J, Randrian V, Tougeron D. Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability. Dig Liver Dis 2023;55:123-30. [PMID: 35397988 DOI: 10.1016/j.dld.2022.03.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Park Y, Nam SK, Seo SH, Park KU, Oh HJ, Park YS, Suh Y, Ahn S, Park DJ, Kim H, Lee HS. Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers. J Gastric Cancer 2023;23. [DOI: 10.5230/jgc.2023.23.e5] [Reference Citation Analysis]
3 Imataki H, Miyake H, Nagai H, Yoshioka Y, Yuasa N, Takamizawa J, Kiriyama A, Fujino M. Diagnosis and clinical implication of collision gastric adenocarcinomas: a case report. Surg Case Rep 2022;8:193. [PMID: 36207547 DOI: 10.1186/s40792-022-01543-1] [Reference Citation Analysis]
4 Zhang H, Huang T, Ren X, Fang X, Chen X, Wei H, Sun W, Wang Y. Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker. Front Genet 2022;13:918486. [DOI: 10.3389/fgene.2022.918486] [Reference Citation Analysis]
5 Wang J, Xi Y, Zhao J, Rong X, Lu W, Wang Y, Mansour-ghanaei F. The Clinicopathological Characteristics and Prognoses of dMMR Gastric Adenocarcinoma Patients. Gastroenterology Research and Practice 2021;2021:1-11. [DOI: 10.1155/2021/4269781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, Molina Roldán E, Cerón Nieto MÁ, García Gómez de Las Heras S, Fernández Aceñero MJ. Are Borrmann's Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study. Cancers (Basel) 2021;13:3081. [PMID: 34205546 DOI: 10.3390/cancers13123081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ahmad A, Mohammed A. Microsatellite instability in gastric carcinomas in Kano, Nigeria. Ann Trop Pathol 2020;11:52. [DOI: 10.4103/atp.atp_3_20] [Reference Citation Analysis]
8 Pereira MA, Ramos MFKP, Dias AR, Faraj SF, Ribeiro RRE, de Castria TB, Zilberstein B, Alves VAF, Ribeiro U Jr, de Mello ES. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1. Mol Diagn Ther 2019;23:761-71. [PMID: 31595457 DOI: 10.1007/s40291-019-00424-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
9 Koh J, Lee KW, Nam SK, Seo AN, Kim JW, Kim JW, Park DJ, Kim HH, Kim WH, Lee HS. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications. Oncologist 2019;24:e1321-30. [PMID: 31371521 DOI: 10.1634/theoncologist.2019-0058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
10 Sun Y, Yu W, Guan W, Cai L, Qiao M, Zheng L, Jiang R, Wang R, Wang L. Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer. Cancer Manag Res 2019;11:6397-410. [PMID: 31372044 DOI: 10.2147/CMAR.S206189] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
11 Hashimoto T, Kurokawa Y, Takahashi T, Miyazaki Y, Tanaka K, Makino T, Yamasaki M, Nakajima K, Ikeda JI, Mori M, Doki Y. Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Gastric Cancer 2019;22:785-92. [PMID: 30617648 DOI: 10.1007/s10120-018-00918-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
12 Klute KA. Moving Away From a One-Size-Fits-All Approach to Gastric Cancer. J Oncol Pract 2018;14:225-6. [PMID: 29641947 DOI: 10.1200/JOP.18.00154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Martinez-Ciarpaglini C, Fleitas-Kanonnikoff T, Gambardella V, Llorca M, Mongort C, Mengual R, Nieto G, Navarro L, Huerta M, Rosello S, Roda D, Tarazona N, Navarro S, Ribas G, Cervantes A. Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications. ESMO Open 2019;4:e000470. [PMID: 31231566 DOI: 10.1136/esmoopen-2018-000470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
14 Shin SJ, Kim SY, Choi YY, Son T, Cheong JH, Hyung WJ, Noh SH, Park CG, Kim HI. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.Oncologist. 2019;24:e835-e844. [PMID: 30894409 DOI: 10.1634/theoncologist.2018-0273] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
15 Haron NH, Mohamad Hanif EA, Abdul Manaf MR, Yaakub JA, Harun R, Mohamed R, Mohamed Rose I. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer. Asian Pac J Cancer Prev 2019;20:509-17. [PMID: 30803214 DOI: 10.31557/APJCP.2019.20.2.509] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zulfiqar M, Bluth MH, Bhalla A. Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update. Clin Lab Med 2018;38:357-65. [PMID: 29776635 DOI: 10.1016/j.cll.2018.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Bouchez C, Kempf E, Tournigand C. Traitement des autres tumeurs solides métastatiques MSI/dMMR. Bulletin du Cancer 2019;106:143-50. [DOI: 10.1016/j.bulcan.2019.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Polom K, Marrelli D, Voglino C, Roviello G, De Franco L, Vindigni C, Generali D, Roviello F. Familial aggregation of gastric cancer with microsatellite instability. Acta Chir Belg 2018;118:287-93. [PMID: 30071769 DOI: 10.1080/00015458.2017.1379789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Machlowska J, Maciejewski R, Sitarz R. The Pattern of Signatures in Gastric Cancer Prognosis. Int J Mol Sci. 2018;19. [PMID: 29867026 DOI: 10.3390/ijms19061658] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
20 Patil PA, Blakely AM, Lombardo KA, Machan JT, Miner TJ, Wang LJ, Marwaha AS, Matoso A. Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma. Histopathology 2018;73:124-36. [PMID: 29489025 DOI: 10.1111/his.13504] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
21 Kim HS, Shin SJ, Beom SH, Jung M, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH, Chung H, Park JC, Shin SK, Lee SK, Lee YC, Koom WS, Lim JS, Chung HC, Rha SY. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.Oncotarget. 2016;44608. [DOI: 10.18632/oncotarget.10115] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
22 Sepulveda AR, J. Del Portillo A. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Yu Y. Molecular classification and precision therapy of cancer: immune checkpoint inhibitors. Front Med. 2018;12:229-235. [PMID: 29209918 DOI: 10.1007/s11684-017-0581-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
24 Yuza K, Nagahashi M, Watanabe S, Takabe K, Wakai T. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017;8:112103-15. [PMID: 29340115 DOI: 10.18632/oncotarget.22783] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
25 Smyth EC, Wotherspoon A, Peckitt C, Gonzalez D, Hulkki-Wilson S, Eltahir Z, Fassan M, Rugge M, Valeri N, Okines A, Hewish M, Allum W, Stenning S, Nankivell M, Langley R, Cunningham D. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial. JAMA Oncol. 2017;3:1197-1203. [PMID: 28241187 DOI: 10.1001/jamaoncol.2016.6762] [Cited by in Crossref: 259] [Cited by in F6Publishing: 289] [Article Influence: 43.2] [Reference Citation Analysis]
26 Hu H, Chen X, Wang C, Jiang Y, Li J, Ying X, Yang Y, Li B, Zhou C, Zhong J, Wu D, Ying J, Duan S. The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer. Oncotarget 2017;8:84054-65. [PMID: 29137404 DOI: 10.18632/oncotarget.21097] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
27 Mathiak M, Warneke VS, Behrens HM, Haag J, Böger C, Krüger S, Röcken C. Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.Appl Immunohistochem Mol Morphol. 2017;25:12-24. [PMID: 26371427 DOI: 10.1097/PAI.0000000000000264] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
28 Ma C, Patel K, Singhi AD, Ren B, Zhu B, Shaikh F, Sun W. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability. Am J Surg Pathol. 2016;40:1496-1506. [PMID: 27465786 DOI: 10.1097/pas.0000000000000698] [Cited by in Crossref: 102] [Cited by in F6Publishing: 111] [Article Influence: 17.0] [Reference Citation Analysis]
29 Ahn S, Lee SJ, Kim Y, Kim A, Shin N, Choi KU, Lee CH, Huh GY, Kim KM, Setia N, Lauwers GY, Park DY. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications. Am J Surg Pathol. 2017;41:106-115. [PMID: 27819872 DOI: 10.1097/pas.0000000000000756] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 10.2] [Reference Citation Analysis]
30 Choi YY, Cheong JH. Beyond precision surgery: Molecularly motivated precision care for gastric cancer. Eur J Surg Oncol 2017;43:856-64. [PMID: 28330821 DOI: 10.1016/j.ejso.2017.02.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
31 Lee HS, Kim WH, Kwak Y, Koh J, Bae JM, Kim KM, Chang MS, Han HS, Kim JM, Kim HW, Chang HK, Choi YH, Park JY, Gu MJ, Lhee MJ, Kim JY, Kim HS, Cho MY; Gastrointestinal Pathology Study Group of Korean Society of Pathologists., Molecular Pathology Study Group of Korean Society of Pathologists. Molecular Testing for Gastrointestinal Cancer. J Pathol Transl Med 2017;51:103-21. [PMID: 28219002 DOI: 10.4132/jptm.2017.01.24] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
32 Xu Q, Chen TJ, He CY, Sun LP, Liu JW, Yuan Y. MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. Sci Rep 2017;7:41307. [PMID: 28150722 DOI: 10.1038/srep41307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
33 Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, Cheong JH, Noh SH, Kim H. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric Cancer 2016;19:1041-51. [PMID: 26573601 DOI: 10.1007/s10120-015-0565-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
34 Goode EF, Smyth EC. Immunotherapy for Gastroesophageal Cancer. J Clin Med. 2016;5. [PMID: 27669318 DOI: 10.3390/jcm5100084] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
35 Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A, Lennerz JK, Hong TS, Kwak EL, Lauwers GY. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol 2016;29:772-84. [PMID: 27032689 DOI: 10.1038/modpathol.2016.55] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 14.7] [Reference Citation Analysis]
36 Gonzalez RS, Messing S, Tu X, McMahon LA, Whitney-Miller CL. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.Hum Pathol. 2016;56:16-21. [PMID: 27342907 DOI: 10.1016/j.humpath.2016.06.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
37 Bae YS, Kim H, Noh SH. Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer. Gut Liver. 2015;9:629-635. [PMID: 26343070 DOI: 10.5009/gnl15133] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
38 Buza N, Ziai J, Hui P. Mismatch repair deficiency testing in clinical practice. Expert Rev Mol Diagn 2016;16:591-604. [PMID: 26895074 DOI: 10.1586/14737159.2016.1156533] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
39 Postlewait LM, Squires MH, Kooby DA, Poultsides GA, Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI, Schmidt CR. Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma. Ann Surg Oncol. 2016;23:1225-1233. [PMID: 26553442 DOI: 10.1245/s10434-015-4953-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
40 Marrelli D, Polom K, Pascale V, Vindigni C, Piagnerelli R, De Franco L, Ferrara F, Roviello G, Garosi L, Petrioli R, Roviello F. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer. Ann Surg Oncol. 2016;23:943-950. [PMID: 26530444 DOI: 10.1245/s10434-015-4931-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
41 Zhang S, Huo X, Li Z, Li X, Tang W, Li C, Guo M, Du X, Chen Z. Microsatellite instability detected in tumor-related genes in C57BL/6J mice with thymic lymphoma induced by N-methyl-N-nitrosourea. Mutat Res 2015;782:7-16. [PMID: 26498208 DOI: 10.1016/j.mrfmmm.2015.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
42 Choi YY, Noh SH, Cheong JH. Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives. J Pathol Transl Med. 2016;50:1-9. [PMID: 26498010 DOI: 10.4132/jptm.2015.09.10] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
43 Feilchenfeldt J, Varga Z, Siano M, Grabsch HI, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Khanfir K, Diebold J, Jochum W, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Hofer S. Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). Br J Cancer 2015;113:716-21. [PMID: 26313663 DOI: 10.1038/bjc.2015.279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
44 Richman S. Deficient mismatch repair: Read all about it (Review). Int J Oncol 2015;47:1189-202. [PMID: 26315971 DOI: 10.3892/ijo.2015.3119] [Cited by in Crossref: 117] [Cited by in F6Publishing: 124] [Article Influence: 14.6] [Reference Citation Analysis]
45 Kim SY, Choi YY, An JY, Shin HB, Jo A, Choi H, Seo SH, Bang H, Cheong J, Hyung WJ, Noh SH. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses: Prognosis of MSI-H gastric cancer. Int J Cancer 2015;137:819-25. [DOI: 10.1002/ijc.29449] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
46 Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R. ARID1A expression in gastric adenocarcinoma: Clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol 2015; 21(7): 2159-2168 [PMID: 25717252 DOI: 10.3748/wjg.v21.i7.2159] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
47 Choi J, Nam SK, Park DJ, Kim HW, Kim H, Kim WH, Lee HS. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma. APMIS 2015;123:215-22. [DOI: 10.1111/apm.12345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
48 Lee EC, Yang JY, Lee KG, Oh SY, Suh YS, Kong SH, Yang HK, Lee HJ. The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection. J Gastric Cancer 2014;14:221-8. [PMID: 25580353 DOI: 10.5230/jgc.2014.14.4.221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
49 Huo X, Zhang S, Li Z, Gao J, Wang C, Li C, Guo M, Du X, Chen Z. Analysis of the relationship between microsatellite instability and thymic lymphoma induced by N-methyl-N-nitrosourea in C57BL/6J mice. Mutat Res 2015;771:21-8. [PMID: 25771976 DOI: 10.1016/j.mrfmmm.2014.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
50 Penon D, Cito L, Giordano A. Novel findings about management of gastric cancer: A summary from 10th IGCC. World J Gastroenterol 2014; 20(27): 8986-8992 [PMID: 25083072 DOI: 10.3748/wjg.v20.i27.8986] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
51 Williams AS, Huang WY. The analysis of microsatellite instability in extracolonic gastrointestinal malignancy. Pathology 2013;45:540-52. [PMID: 24018804 DOI: 10.1097/PAT.0b013e3283653307] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
52 Choi YY, Bae JM, An JY, Kwon IG, Cho I, Shin HB, Eiji T, Aburahmah M, Kim HI, Cheong JH. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol. 2014;110:129-135. [PMID: 24737677 DOI: 10.1002/jso.23618] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 9.0] [Reference Citation Analysis]
53 Wiegand KC, Sy K, Kalloger SE, Li-Chang H, Woods R, Kumar A, Streutker CJ, Hafezi-Bakhtiari S, Zhou C, Lim HJ. ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts. Hum Pathol. 2014;45:1258-1268. [PMID: 24767857 DOI: 10.1016/j.humpath.2014.02.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
54 Kim K, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, Kang GH. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Human Pathology 2014;45:285-93. [DOI: 10.1016/j.humpath.2013.09.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 8.7] [Reference Citation Analysis]
55 Choi HS, Lee SY, Kim JH, Sung IK, Park HS, Shim CS, Jin CJ, Han HS. Low prevalence of microsatellite instability in interval gastric cancers. Dig Dis Sci 2014;59:322-7. [PMID: 24357187 DOI: 10.1007/s10620-013-2987-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Mao YT, Liu JL, Wang Z, Chen YY, Chen JQ. Relationship between hMLH1 methylation, microsatellite instability and gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(35): 3954-3960 [DOI: 10.11569/wcjd.v21.i35.3954] [Reference Citation Analysis]
57 Wang F, Sun GP, Zou YF, Zhong F, Ma T, Li XQ, Wu D. Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer. Curr Oncol. 2013;20:e388-e395. [PMID: 24155636 DOI: 10.3747/co.20.1417] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
58 Zulfiqar M, Bhalla A, Weindel M, Shidham VB. Molecular diagnostics in esophageal and gastric neoplasms. Clin Lab Med. 2013;33:867-873. [PMID: 24267191 DOI: 10.1016/j.cll.2013.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
59 Arai T, Sakurai U, Sawabe M, Honma N, Aida J, Ushio Y, Kanazawa N, Kuroiwa K, Takubo K. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. Gastric Cancer 2013;16:505-12. [PMID: 23274922 DOI: 10.1007/s10120-012-0226-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
60 Kim JW, Im S, Kim MA, Cho HJ, Lee DW, Lee K, Kim T, Han S, Oh D, Lee H, Kim T, Yang H, Kim WH, Bang Y. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker: The prognostic value of ATM and MSI in gastric cancer. Int J Cancer 2014;134:72-80. [DOI: 10.1002/ijc.28245] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
61 Park HJ, Kim HS, Kim JW, Park SY, Kim BR, Ryu HY, Lee IY, Lee YK, Cho MY. Is microsatellite instability (MSI) associated with multiplicity in early stage gastric neoplasias? Clin Res Hepatol Gastroenterol 2013;37:400-5. [PMID: 23273496 DOI: 10.1016/j.clinre.2012.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
62 Lee HS, Hwang SM, Kim TS, Kim DW, Park DJ, Kang SB, Kim HH, Park KU. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. Transl Oncol. 2013;6:290-296. [PMID: 23730408 DOI: 10.1593/tlo.13118] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
63 Wang F, Sun G, Zou Y, Zhong F, Ma T, Li X. Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer. PLoS One 2013;8:e62440. [PMID: 23667477 DOI: 10.1371/journal.pone.0062440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
64 Kim JY, Shin NR, Kim A, Lee HJ, Park WY, Kim JY, Lee CH, Huh GY, Park do Y. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol. 2013;47:28-35. [PMID: 23483099 DOI: 10.4132/koreanjpathol.2013.47.1.28] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
65 Sepulveda AR. Helicobacter, Inflammation, and Gastric Cancer. Curr Pathobiol Rep. 2013;1:9-18. [PMID: 23687623 DOI: 10.1007/s40139-013-0009-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
66 Harada S, Sepulveda AR. Molecular Mechanisms and Pathology of Gastric Carcinogenesis: Sporadic Cancers. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_5] [Reference Citation Analysis]
67 Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation. Hum Pathol. 2013;44:1055-1064. [PMID: 23266441 DOI: 10.1016/j.humpath.2012.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
68 Fang WL, Chang SC, Lan YT, Huang KH, Chen JH, Lo SS, Hsieh MC, Li AF, Wu CW, Chiou SH. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery. World J Surg. 2012;36:2131-2138. [PMID: 22669398 DOI: 10.1007/s00268-012-1652-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
69 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
70 Mazzolini R, Rodrigues P, Bazzocco S, Dopeso H, Ferreira AM, Mateo-Lozano S, Andretta E, Woerner SM, Alazzouzi H, Landolfi S, Hernandez-Losa J, Macaya I, Suzuki H, Ramón y Cajal S, Mooseker MS, Mariadason JM, Gebert J, Hofstra RM, Reventós J, Yamamoto H, Schwartz S Jr, Arango D. Brush border myosin Ia inactivation in gastric but not endometrial tumors. Int J Cancer 2013;132:1790-9. [PMID: 23002058 DOI: 10.1002/ijc.27856] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
71 Jahng J, Youn YH, Kim KH, Yu J, Lee YC, Hyung WJ, Noh SH, Kim H, Kim H, Park H, Lee SI. Endoscopic and clinicopathologic characteristics of early gastric cancer with high microsatellite instability. World J Gastroenterol 2012; 18(27): 3571-3577 [PMID: 22826622 DOI: 10.3748/wjg.v18.i27.3571] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
72 Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol 2012;47:351-8. [PMID: 22402775 DOI: 10.1007/s00535-012-0565-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
73 Nadauld LD, Ford JM. Family history as a positive prognostic factor in gastric cancer. J Clin Oncol 2012;30:683-4. [PMID: 22271484 DOI: 10.1200/JCO.2011.40.1497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
74 An JY, Kim H, Cheong JH, Hyung WJ, Kim H, Noh SH. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer. 2012;131:505-511. [PMID: 21898388 DOI: 10.1002/ijc.26399] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 7.6] [Reference Citation Analysis]
75 Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22 Suppl 5:v1-v9. [PMID: 21633049 DOI: 10.1093/annonc/mdr284] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 7.6] [Reference Citation Analysis]
76 Bae JM, Kim MJ, Kim JH, Koh JM, Cho N, Kim T, Kang GH. Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status. Virchows Arch 2011;459:55-63. [DOI: 10.1007/s00428-011-1080-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
77 Kim H, An JY, Noh SH, Shin SK, Lee YC, Kim H. High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol 2011;26:585-92. [PMID: 21332554 DOI: 10.1111/j.1440-1746.2010.06487.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
78 Jang B, Kim WH. Molecular Pathology of Gastric Carcinoma. Pathobiology 2011;78:302-10. [DOI: 10.1159/000321703] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
79 Shin N, Kim H, Kim W, Park M, Kim K, Shin DH, Choi K, Kim J, Lee CH, Huh GY, Sol MY, Park DY. Molecular Biological Characteristics of Differentiated Early Gastric Cancer on the Basis of Mucin Expression. Korean J Pathol 2011;45:69. [DOI: 10.4132/koreanjpathol.2011.45.1.69] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Ling ZQ, Tanaka A, Li P, Nakayama T, Fujiyama Y, Hattori T, Sugihara H. Microsatellite instability with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma. Cancer Lett. 2010;297:244-251. [PMID: 20831982 DOI: 10.1016/j.canlet.2010.05.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
81 Jeong CW, Lee JH, Sohn SS, Ryu SW, Kim DK. Mitochondrial microsatellite instability in gastric cancer and gastric epithelial dysplasia as a precancerous lesion. Cancer Epidemiol. 2010;34:323-327. [PMID: 20409774 DOI: 10.1016/j.canep.2010.03.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
82 Kwon J, Lee J, Jee YS, Park D, Kim H, Lee H, Yang H, Lee KU, Lee HS. Overexpression ofp53, Mutation ofhMLH1and Microsatellite Instability in Gastric Carcinomas: Clinicopathologic Implications and Prognosis. J Korean Surg Soc 2010;79:94. [DOI: 10.4174/jkss.2010.79.2.94] [Reference Citation Analysis]
83 Sepulveda AR, Lynch JP. Genetic Instability and Chronic Inflammation in Gastrointestinal Cancers. Cancer Genome and Tumor Microenvironment 2010. [DOI: 10.1007/978-1-4419-0711-0_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Choi JS, Kim MA, Lee HE, Lee HS, Kim WH. Mucinous gastric carcinomas: clinicopathologic and molecular analyses. Cancer. 2009;115:3581-3590. [PMID: 19479974 DOI: 10.1002/cncr.24422] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
85 Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, Ohgaki K, Morita M, Maehara Y. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol. 2009;16:2510-2515. [PMID: 19565284 DOI: 10.1245/s10434-009-0580-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
86 Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol. 2009;33:691-704. [PMID: 19252434 DOI: 10.1097/pas.0b013e3181983ef7] [Cited by in Crossref: 88] [Cited by in F6Publishing: 97] [Article Influence: 6.3] [Reference Citation Analysis]
87 Seo HM, Chang YS, Joo SH, Kim YW, Park YK, Hong SW, Lee SH. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol. 2009;99:143-147. [PMID: 19117018 DOI: 10.1002/jso.21220] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
88 Elistratova EV, Laktionov PP, Shelestuk PI, Tuzikov SA, Vlassov VV, Rykova EY. Immunochemical and molecular-Genetic markers in diagnostics of gastric cancer. Biochem Moscow Suppl Ser B 2009;3:33-43. [DOI: 10.1134/s1990750809010041] [Reference Citation Analysis]
89 Sepulveda AR, Aisner DL. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2009. [DOI: 10.1016/b978-0-12-374419-7.00019-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
90 Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, Mckee PH, Lev D, Lyle S, Calonje E, Lazar AJF. Site and Tumor Type Predicts DNA Mismatch Repair Status in Cutaneous Sebaceous Neoplasia. American Journal of Surgical Pathology 2008;32:936-42. [DOI: 10.1097/pas.0b013e31815b0cc2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.1] [Reference Citation Analysis]
91 Falchetti M, Saieva C, Lupi R, Masala G, Rizzolo P, Zanna I, Ceccarelli K, Sera F, Mariani-Costantini R, Nesi G. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival. Hum Pathol. 2008;39:925-932. [PMID: 18440592 DOI: 10.1016/j.humpath.2007.10.024] [Cited by in Crossref: 86] [Cited by in F6Publishing: 103] [Article Influence: 5.7] [Reference Citation Analysis]
92 Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 2008;266:99-115. [PMID: 18381231 DOI: 10.1016/j.canlet.2008.02.053] [Cited by in Crossref: 86] [Cited by in F6Publishing: 95] [Article Influence: 5.7] [Reference Citation Analysis]
93 Ottini L, Falchetti M, Lupi R, Rizzolo P, Agnese V, Colucci G, Bazan V, Russo A. Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol. 2006;17 Suppl 7:vii97-vi102. [PMID: 16760303 DOI: 10.1093/annonc/mdl960] [Cited by in Crossref: 105] [Cited by in F6Publishing: 120] [Article Influence: 7.0] [Reference Citation Analysis]
94 Heatley MK. Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis. Histopathology 2008;52:267-76. [DOI: 10.1111/j.1365-2559.2007.02824.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
95 Gazvoda B, Juvan R, Zupanic-Pajnic I, Repse S, Ferlan-Marolt K, Balazic J, Komel R. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA. Eur J Gastroenterol Hepatol 2007;19:1082-9. [PMID: 17998833 DOI: 10.1097/MEG.0b013e3282f13cf9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
96 An JY, Choi MG, Noh JH, Kim KM, Kim DS, Sohn TS, Kim S. Stage IV early gastric cancer: two cases with microsatellite instability. Langenbecks Arch Surg 2008;393:105-9. [PMID: 17917741 DOI: 10.1007/s00423-007-0228-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Sakurai M, Zhao Y, Oki E, Kakeji Y, Oda S, Maehara Y. High-resolution fluorescent analysis of microsatellite instability in gastric cancer. Eur J Gastroenterol Hepatol 2007;19:701-9. [PMID: 17625441 DOI: 10.1097/MEG.0b013e3281ac20a8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
98 Beghelli S, de Manzoni G, Barbi S, Tomezzoli A, Roviello F, Di Gregorio C, Vindigni C, Bortesi L, Parisi A, Saragoni L. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery. 2006;139:347-356. [PMID: 16546499 DOI: 10.1016/j.surg.2005.08.021] [Cited by in Crossref: 101] [Cited by in F6Publishing: 109] [Article Influence: 5.9] [Reference Citation Analysis]
99 Oda S, Zhao Y, Maehara Y. Microsatellite instability in gastrointestinal tract cancers: a brief update. Surg Today 2005;35:1005-15. [PMID: 16341479 DOI: 10.1007/s00595-005-3125-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
100 Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: Underlying molecular and cellular mechanisms. World J Gastroenterol 2006; 12(11): 1671-1680 [PMID: 16586533 DOI: 10.3748/wjg.v12.i11.1671] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
101 Saetta AA. K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. J Surg Oncol 2006;93:644-9. [DOI: 10.1002/jso.20532] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
102 Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006;20:651-74. [PMID: 16997151 DOI: 10.1016/j.bpg.2006.03.016] [Cited by in Crossref: 106] [Cited by in F6Publishing: 115] [Article Influence: 6.2] [Reference Citation Analysis]
103 Aparicio T, Yacoub M, Karila-cohen P, René E. Adénocarcinome gastrique : notions fondamentales, diagnostic et traitement. EMC - Gastro-entérologie 2006;1:1-12. [DOI: 10.1016/s1155-1968(06)74179-7] [Reference Citation Analysis]
104 Motoshita J, Oue N, Nakayama H, Kuraoka K, Aung PP, Taniyama K, Matsusaki K, Yasui W. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci. 2005;96:474-479. [PMID: 16108828 DOI: 10.1111/j.1349-7006.2005.00074.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
105 Willems S, Carneiro F, Geboes K. Gastric carcinoma with osteoclast-like giant cells and lymphoepithelioma-like carcinoma of the stomach: two of a kind? Histopathology 2005;47:331-3. [DOI: 10.1111/j.1365-2559.2005.02135.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
106 Teramoto K, Tada M, Tamoto E, Abe M, Kawakami A, Komuro K, Matsunaga A, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Shirata K, Takahishi T, Ishizu A, Ikeda H, Hamada J, Kondo S, Katoh H, Moriuchi T, Yoshiki T. Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling. J Surg Res 2005;124:225-36. [PMID: 15820252 DOI: 10.1016/j.jss.2004.10.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
107 Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005;25:197-222. [PMID: 15749238 DOI: 10.1016/j.cll.2004.12.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
108 An C, Choi I, Yao JC, Worah S, Xie K, Mansfield PF, Ajani JA, Rashid A, Hamilton SR, Wu T. Prognostic Significance of CpG Island Methylator Phenotype and Microsatellite Instability in Gastric Carcinoma. Clinical Cancer Research 2005;11:656-63. [DOI: 10.1158/1078-0432.656.11.2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
109 Migliavacca M, Ottini L, Bazan V, Agnese V, Corsale S, Macaluso M, Lupi R, Dardanoni G, Valerio MR, Pantuso G. TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome. J Cell Physiol. 2004;200:476-485. [PMID: 15254976 DOI: 10.1002/jcp.20053] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
110 Aparicio T, Yacoub M, Karila-cohen P, René E. Adénocarcinome gastrique : notions fondamentales, diagnostic et traitement. EMC - Chirurgie 2004;1:47-66. [DOI: 10.1016/j.emcchi.2003.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
111 Debruyne PR, Waldman SA, Schulz S. Pathological staging and therapy of oesophageal and gastric cancer. Expert Opin Pharmacother 2003;4:1083-96. [PMID: 12831335 DOI: 10.1517/14656566.4.7.1083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
112 Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol 2003;200:23-31. [PMID: 12692837 DOI: 10.1002/path.1325] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 3.0] [Reference Citation Analysis]
113 Lim S, Lee HS, Kim HS, Kim YI, Kim WH. Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers. Histopathology 2003;42:128-36. [PMID: 12558744 DOI: 10.1046/j.1365-2559.2003.01546.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]